Zika Virus Vaccine Research and Development Roadmap Announced
The WHO announced the Center for Infectious Disease Research and Policy at the University of Minnesota, the University of Texas Medical Branch, an expert team of task force members worldwide had developed a draft Zika virus (ZIKV) Research and Development (R&D) Roadmap.
The Roadmap, released on February 17, 2021, is a key component of the WHO’s R&D Blueprint, a global strategy and preparedness plan that allows the activation of R&D activities in advance of and during epidemics.
The purpose of the roadmap is to accelerate the development and implementation of effective medical countermeasures for ZIKV to reduce morbidity, mortality, and transmission. The roadmap identifies the vision, strategic goals, and aligned milestones to develop effective diagnostics, therapeutic agents, and vaccines for ZIKV.